Head-to-head comparison of FAP-targeting single-domain antibody 4AH29 vs. peptide FAP-2286.

lutetium Lu 177 rofapitide tetraxetan (AAA614) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/41688618

Ana Rita Pombo Antunes; Dimitrios Mantzilas; Joar Pinto; Jonatan Dewulf; Laurent Navarro; Marion Berdal; Matthias D'huyvetter; Mira Van Eesbeek; Nina Dumauthioz; Silke Plas; Surasa Nagachinta

Feb 14, 2026